JiangXi Tianxin Pharm Co Ltd
JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, a-acetyl-"-butyrolactone, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as i… Read more
Market Cap & Net Worth: JiangXi Tianxin Pharm Co Ltd (603235)
JiangXi Tianxin Pharm Co Ltd (SHG:603235) has a market capitalization of $1.69 Billion (CN¥12.38 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #16204 globally and #4305 in its home market, demonstrating a 2.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JiangXi Tianxin Pharm Co Ltd's stock price CN¥28.27 by its total outstanding shares 437780000 (437.78 Million).
JiangXi Tianxin Pharm Co Ltd Market Cap History: 2022 to 2026
JiangXi Tianxin Pharm Co Ltd's market capitalization history from 2022 to 2026. Data shows change from $1.66 Billion to $1.69 Billion (-14.75% CAGR).
JiangXi Tianxin Pharm Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JiangXi Tianxin Pharm Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.69x
JiangXi Tianxin Pharm Co Ltd's market cap is 0.69 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
2.34x
JiangXi Tianxin Pharm Co Ltd's market cap is 2.34 times its annual earnings
5.50x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.66 Billion | $2.30 Billion | $622.12 Million | 0.72x | 2.67x |
| 2023 | $1.41 Billion | $1.88 Billion | $475.85 Million | 0.75x | 2.95x |
| 2024 | $1.53 Billion | $2.21 Billion | $651.22 Million | 0.69x | 2.34x |
Competitor Companies of 603235 by Market Capitalization
Companies near JiangXi Tianxin Pharm Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to JiangXi Tianxin Pharm Co Ltd by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
JiangXi Tianxin Pharm Co Ltd Historical Marketcap From 2022 to 2026
Between 2022 and today, JiangXi Tianxin Pharm Co Ltd's market cap moved from $1.66 Billion to $ 1.69 Billion, with a yearly change of -14.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.69 Billion | +4.82% |
| 2025 | CN¥1.61 Billion | +5.52% |
| 2024 | CN¥1.53 Billion | +8.49% |
| 2023 | CN¥1.41 Billion | -15.38% |
| 2022 | CN¥1.66 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of JiangXi Tianxin Pharm Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.69 Billion USD |
| MoneyControl | $1.69 Billion USD |
| MarketWatch | $1.69 Billion USD |
| marketcap.company | $1.69 Billion USD |
| Reuters | $1.69 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.